{
    "Trade/Device Name(s)": [
        "MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5 - 64 \u00b5g/mL)"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K202343",
    "Predicate Device Reference 510(k) Number(s)": [
        "K193536"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY",
        "LTT",
        "LRG",
        "LTW"
    ],
    "Summary Letter Date": "November 16, 2020",
    "Summary Letter Received Date": "August 18, 2020",
    "Submission Date": "August 13, 2020",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of rapidly growing aerobic and facultative anaerobic gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "WalkAway instrument",
        "autoSCAN-4 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Dehydrated broth dilution",
        "Automated panel reading"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Dried Gram-Negative MIC/Combo Panels with ceftazidime for antimicrobial susceptibility testing.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility of colonies of rapidly growing aerobic and facultative anaerobic gram-negative bacilli.",
    "fda_folder": "Microbiology"
}